Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).

Suppr

超能文献

作者信息

FRIEDMAN A P, LOSIN S

出版信息

Arch Neurol. 1961 Mar;4:241-5. doi: 10.1001/archneur.1961.00450090007002.

DOI:10.1001/archneur.1961.00450090007002

PMID:13701987

Abstract

摘要

相似文献

Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).

Arch Neurol. 1961 Mar;4:241-5. doi: 10.1001/archneur.1961.00450090007002.

Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.

Angiology. 1960 Aug;11:364-6. doi: 10.1177/000331976001100409.

THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.1-甲基-D-麦角酸丁醇酰胺（美西麦角）治疗血管性头痛的预防作用。一项临床研究。

Med Exp Int J Exp Med. 1964;10:137-43. doi: 10.1159/000135408.

Prophylaxis of frequent vascular headache with methysergide.

Am J Med Sci. 1962 Jan;243:92-8. doi: 10.1097/00000441-196201000-00014.

Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.

Med Exp Int J Exp Med. 1960;2:36-9. doi: 10.1159/000134839.

Studies in headache: further analysis of the mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.

Trans Am Neurol Assoc. 1961;86:95-8.

Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.

Arch Neurol. 1961 Mar;4:235-40. doi: 10.1001/archneur.1961.00450090001001.

Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.1-甲基麦角酰胺对偏头痛的预防和治疗作用

Int Arch Allergy Appl Immunol. 1959;15:300-7. doi: 10.1159/000229055.

The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches.

S Afr Med J. 1963 Jun 15;37:631-7.

[First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects].

Prog Med (Napoli). 1960 Jan 15;16:20-2.

引用本文的文献

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention.欧洲头痛联合会关于使用作用于降钙素基因相关肽或其受体的单克隆抗体预防偏头痛的指南。

J Headache Pain. 2019 Jan 16;20(1):6. doi: 10.1186/s10194-018-0955-y.

CLINICAL TRIAL OF METHYSERGIDE AND OTHER PREPARATIONS IN THE MANAGEMENT OF MIGRAINE.麦角新碱及其他制剂治疗偏头痛的临床试验

J Neurol Neurosurg Psychiatry. 1964 Oct;27(5):463-9. doi: 10.1136/jnnp.27.5.463.

METHYSERGIDE FOR MIGRAINE.用于治疗偏头痛的麦角新碱

Br Med J. 1964 May 23;1(5394):1332.

METHYSERGIDE (SANSERT) IN THE PREVENTION OF MIGRAINE: A CLINICAL TRIAL.甲基麦角新碱（Sansert）预防偏头痛的临床试验

Can Med Assoc J. 1963 Dec 14;89(24):1221-3.

Management of trigeminal autonomic cephalgias and hemicrania continua.三叉神经自主性头痛和持续性偏侧头痛的管理。

Drugs. 2003;63(16):1637-77. doi: 10.2165/00003495-200363160-00002.

Research in migraine.偏头痛研究

Br Med J. 1966 May 28;1(5499):1315-6.

Prophylaxis of recurrent headache.复发性头痛的预防

Br Med J. 1969 Jan 4;1(5635):5-6.

Cluster migraine--an unrecognized common entity.丛集性偏头痛——一种未被认识的常见病症。

Can Med Assoc J. 1970 Nov 7;103(10):1026-30.

Methysergide in prophylaxis of migraine: a clinical trial in general practice.麦角新碱预防偏头痛：一项全科医疗中的临床试验。

Br Med J. 1966 Aug 13;2(5510):394-5. doi: 10.1136/bmj.2.5510.394.

Migraine in a rural practice (1958-1963). A five-year study of a controlled clinical trial.农村医疗实践中的偏头痛（1958 - 1963年）。一项对照临床试验的五年研究。

J Coll Gen Pract. 1965 Nov;10(3):230-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验